SCHEMBL17625839

SCHEMBL17625839

C=C(C)C(=O)Oc1ccc(/C=C/c2ccc(-c3cc(C)c(-c4ccc(OC(=O)C(=C)C)cc4)cc3OC(=O)C(=C)C)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.45
KMT2A Q03164 4/20 0.43
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
TTR P02766 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
ELANE P08246 1/20 0.41
TUBB4A P04350 3/20 0.40
TUBB P07437 3/20 0.40
TUBA3C P0DPH7 3/20 0.40
TUBA1B P68363 3/20 0.40
TUBA4A P68366 3/20 0.40
TUBB4B P68371 3/20 0.40
TUBB3 Q13509 3/20 0.40
TUBB2A Q13885 3/20 0.40
TUBB8 Q3ZCM7 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17625681 0.92 BACE1 (0.51) BACE1KMT2ALMNAELANEATM
SCHEMBL17625747 0.91 BACE1 (0.50) BACE1KMT2ALMNAMAPTELANE
SCHEMBL17625828 0.90 KMT2A (0.41) BACE1KMT2AKDM4ESMN1; SMN2MEN1
SCHEMBL17625785 0.90 KMT2A (0.41) BACE1KMT2AKDM4ESMN1; SMN2MEN1
SCHEMBL17625867 0.88 BACE1 (0.45) BACE1KMT2AKDM4ESMN1; SMN2MEN1
SCHEMBL20275906 0.87 ELANE (0.51) BACE1KMT2ASMN1; SMN2LMNAMAPT
SCHEMBL17625812 0.86 BACE1 (0.44) BACE1KMT2AELANEATMNFKB1
SCHEMBL17625832 0.86 BACE1 (0.46) BACE1KMT2AKDM4EMEN1LMNA
SCHEMBL17625757 0.86 TUBB4A (0.46) BACE1KMT2AKDM4ESMN1; SMN2MEN1
SCHEMBL17589357 0.85 BACE1 (0.58) BACE1KMT2AKDM4ESMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160152895-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2016-06-02 US disclosed
US-20160152895-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2016-06-02 US disclosed
EP-3020700-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2016-05-18 EP disclosed
WO-2015004947-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC株式会社 (JP) 2015-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160152895-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE CCDC47, NCAPD2, CCDC22 BACE1 3961/4885KMT2A 3586/4885KDM4E 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.